Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
about
Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium saltZanamivir: from drug design to the clinicIn vitro and in vivo inhibition of ortho- and paramyxovirus infections by a new class of sulfonic acid polymers interacting with virus-cell binding and/or fusionSusceptibilities to rimantadine of influenza A/H1N1 and A/H3N2 viruses isolated during the epidemics of 1988 to 1989 and 1989 to 19904-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitroDrug resistance in influenza A virus: the epidemiology and management.New aspects of influenza viruses.Antiviral therapy of influenza.Role of combination antiviral therapy in pandemic influenza and stockpiling implications.Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008.A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.Emerging antiviral strategies to interfere with influenza virus entry.Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine.Approaches and strategies for the treatment of influenza virus infections.Effectiveness and role of zanamivir in the treatment of influenza infection.Mapping the energy surface of transmembrane helix-helix interactionsAdamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.Safety and prophylactic efficacy of low-dose rimantadine in adults during an influenza A epidemic.Antiviral therapy: current concepts and practicesDetection of adamantane-resistant influenza on a microarrayBovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus.Crucial role of PA in virus life cycle and host adaptation of influenza A virus.Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in JapanIdentification of GS 4104 as an orally bioavailable prodrug of the influenza virus neuraminidase inhibitor GS 4071.Detection of amantadine-resistant influenza A virus strains in nursing homes by PCR-restriction fragment length polymorphism analysis with nasopharyngeal swabs.Frequency of amantadine-resistant influenza A viruses during two seasons featuring cocirculation of H1N1 and H3N2.Rimantadine: a clinical perspective.Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method.Amantadine for influenza A.Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan.Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)InfluenzaSynthetic sialic-acid-containing polyvalent antiviral inhibitors
P2860
Q28328612-909F9B95-E5F5-4CC9-A783-F24669FBFF33Q28344586-AB609DEA-45DA-42B9-8E49-6388C045DB59Q28369718-C44A6C10-6692-403C-9A7E-00C03CED659FQ28378405-6A21FA74-76DA-4F23-AADE-E4E5C209F661Q28378588-A228C455-73C1-4BAE-A5E5-44AF3C414F26Q30234600-DE7DFE30-544A-4698-89AD-E4E757252676Q30333613-91370364-2F94-4B67-AC5E-4A53A11AD3ACQ30350565-7A9EE860-B21A-4596-B064-1D8D5FDFE945Q30359766-70676608-A843-4352-A88D-95FCDED04E53Q30382408-C2F057BC-A4F2-41F8-ACC4-A3639D715A21Q30393843-5AAD57B8-D2F3-4E46-924C-4B107062DE7CQ30432421-9183697A-7B49-4935-9137-21ECB895DC4EQ30448585-195E38B2-F79E-4815-A2E9-FC74E631E10EQ33730165-FA839E3F-DE80-4357-A216-2BC2979D6804Q33780690-93A54B4D-AFCC-4C9F-8CE7-1878860134CFQ34176789-747D1FCE-C522-4D55-91B3-FA95DF10022FQ35175284-A60283C9-13C2-4051-B688-115AB278AC96Q35271460-259089D3-CC0E-4A1F-B9F9-92313351A648Q36070394-747485AF-8E9A-4F1A-9394-E9D90F43F3CAQ36804784-BBA67E9D-BA2F-4BC3-8A15-9AF7DA64E463Q37726584-A899334E-4CA8-4693-AAC2-051E74B1C7D3Q38234789-2E9E805C-A5DF-41CD-9F36-6F77C66A4E08Q39464368-CAA11F76-E22C-41BA-875E-BEBFD738D02EQ39557208-8802BA8F-10BA-4976-B756-9DF7951CA95AQ39626221-FC7D09BF-BA3D-4463-834E-6BFCB06990A4Q39751284-B06AAFC6-1E88-4AEC-807E-148715C0C092Q40441770-D083DFD6-16E2-4167-A690-5B2AA8B2A54CQ42929558-F7DD5737-8804-43B2-AB10-A02617FDDC78Q43165454-F4F1EBDA-8DD6-4A15-B49D-A3D0341EC840Q43209459-9228A331-44E1-4BFD-8CB9-8FA73978C266Q43247402-EF1BC14F-0E9A-4D9C-9AC7-584D63D76C8DQ56675602-211F1C8C-3601-46CD-99B8-A88DA29A820CQ57028463-E44A0009-346C-4AD3-A0E6-A9FF9497F4E9Q57346398-1D362AAB-FEE8-4041-9CF3-85A1FC718B20
P2860
Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Resistance of influenza A viru ...... of one decade of surveillance.
@en
type
label
Resistance of influenza A viru ...... of one decade of surveillance.
@en
prefLabel
Resistance of influenza A viru ...... of one decade of surveillance.
@en
P2093
P356
P1476
Resistance of influenza A viru ...... of one decade of surveillance.
@en
P2093
P304
P356
10.1093/INFDIS/159.3.430
P407
P577
1989-03-01T00:00:00Z